Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07816614

The Effect of Mandala Coloring on Quality of Life in Cancer Patients

This study aims to determine the effect of mandala coloring on the quality of life in cancer patients. Conducting a quasi-experimental design with a pretest-posttest control group, the study will involve a total of 76 cancer patients hospitalized in an oncology ward. Participants will be assigned to either the experimental (mandala) group or the control group. At the baseline, data will be collected face-to-face using a Patient Information Form and the EORTC QLQ-C30 Version 3.0 Quality of Life Scale. Patients in the experimental group will be provided with a mandala coloring book and colored pencils, and they will practice mandala coloring for 30 minutes, at least twice a week, over a 3-week period. The control group will receive routine clinical care with no intervention. After 3 weeks, the EORTC QLQ-C30 scale will be re-administered to both groups to evaluate and compare changes in their quality of life.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with cancer
  • Aged 18 years and older
  • Voluntarily willing to participate in the study
  • Able to hold and use a pencil for coloring

Exclusion criteria

  • Refusing to participate or withdraws consent before the study begins
  • Unable to comply regularly with the scheduled mandala coloring program
  • Incapable of using a pencil due to physical or cognitive impairments

Treatment and study plan

Mandala Coloring

Behavioral

Patients in the experimental group will be provided with a mandala coloring book and a set of 12 colored pencils. They will be requested to practice mandala coloring in a quiet, distraction-free environment for 30 minutes, at least twice a week, for a total duration of 3 weeks. The intervention will be conducted in addition to routine clinical care.

Other names: Experimental Group

Primary outcomes

  1. Quality of Life Score via EORTC QLQ-C30

    Time frame: Baseline and 3 weeks

    Quality of life will be evaluated using the EORTC QLQ-C30 Version 3.0 Quality of Life Scale.

Study contacts

Contact information is provided by the study sponsor or research team.

Emine Tarlabelen Karaytug, Research Assistant, PhD

CONTACT

[email protected]

+90-531-384-2926

Sponsors and collaborators

Lead sponsor

Emine TARLABELEN KARAYTUĞ

Other

Collaborators

  • The Scientific and Technological Research Council of Turkey

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Sep 11, 2026
Registry last updated
Sep 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.